| Signaling in fibrosis: TGF-β, WNT, and YAP/TAZ converge B Piersma, RA Bank, M Boersema Frontiers in medicine 2, 59, 2015 | 540 | 2015 |
| Fibrosis and cancer: A strained relationship B Piersma, MK Hayward, VM Weaver Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1873 (2), 188356, 2020 | 530 | 2020 |
| YAP1 is a driver of myofibroblast differentiation in normal and diseased fibroblasts B Piersma, S de Rond, PMN Werker, S Boo, B Hinz, MM van Beuge, ... The American journal of pathology 185 (12), 3326-3337, 2015 | 148 | 2015 |
| Collagen cross-linking mediated by lysyl hydroxylase 2: an enzymatic battlefield to combat fibrosis B Piersma, RA Bank Essays in biochemistry 63 (3), 377-387, 2019 | 76 | 2019 |
| Ascorbic acid promotes a TGFβ1‐induced myofibroblast phenotype switch B Piersma, OY Wouters, S de Rond, M Boersema, RAF Gjaltema, ... Physiological reports 5 (17), e13324, 2017 | 44 | 2017 |
| Inhibition of tyrosine kinase receptor signaling attenuates fibrogenesis in an ex vivo model of human renal fibrosis E Bigaeva, EGD Stribos, HAM Mutsaers, B Piersma, AM Leliveld, ... American Journal of Physiology-Renal Physiology 318 (1), F117-F134, 2020 | 22 | 2020 |
| Signaling in Fibrosis: TGF-beta, WNT, and YAP/TAZ Converge. Front Med (Lausanne). 2015; 2: 59 B Piersma, RA Bank, M Boersema Epub 2015/09/22. https://doi. org/10.3389/fmed. 2015.00059 PMID: 26389119, 2015 | 16 | 2015 |
| Signaling in fibrosis: TGF-β, WNT, and YAP/TAZ converge. Front Med. 2015 B Piersma, RA Bank, M Boersema | 14 | 2015 |
| A genome-wide association meta-analysis implicates Hedgehog and Notch signaling in Dupuytren’s disease SA Riesmeijer, Z Kamali, M Ng, D Drichel, B Piersma, K Becker, ... Nature Communications 15 (1), 199, 2024 | 10 | 2024 |
| Keeping fibroblasts in suspense: TAZ-mediated signaling activates a context-dependent profibrotic phenotype. Focus on “TAZ activation drives fibroblast spheroid … B Piersma, RA Bank American Journal of Physiology-Cell Physiology 312 (3), C274-C276, 2017 | 5 | 2017 |
| αII-spectrin and βII-spectrin do not affect TGFβ1-induced myofibroblast differentiation B Piersma, OY Wouters, RA Bank Cell and tissue research 374, 165-175, 2018 | 4 | 2018 |
| Verteporfin ameliorates fibrotic aspects of Dupuytren’s disease nodular fibroblasts irrespective the activation state of the cells N Puerta Cavanzo, SA Riesmeijer, IL Holt-Kedde, PMN Werker, ... Scientific Reports 12 (1), 13940, 2022 | 3 | 2022 |
| Optimal control of DC grids B Piersma | | 2023 |
| Verteporfin Improves Fibrotic Aspects of Dupuytren’s Disease Nodular Fibroblasts, Irrespective of Activation State NP Cavanzo, SA Riesmeijer, IL Holt-Kedde, PMN Werker, B Piersma, ... THE POTENTIAL OF IN VITRO AND EX VIVO MODELS TO PREDICT THE EFFICACY OF …, 2021 | | 2021 |
| αII-SPECTRIN AND βII-SPECTRIN DO NOT AFFECT FIBROBLAST MECHANOSENSING AND TGFΒ1-INDUCED MYOFIBROBLAST DIFFERENTIATION OY Wouters, B Piersma, RA Bank MECHANOBIOLOGICAL ASPECTS OF (DYSREGULATED) WOUND HEALING AND THE FOREIGN …, 2017 | | 2017 |
| Keeping fibroblasts in suspense: TAZ mediated signaling activates a context dependent 1 pro-fibrotic phenotype 2 B Piersma, RA Bank | | 2017 |
| Biochemical and biomechanical regulation of the myofibroblast phenotype: focus on Hippo and TGFβ signaling B Piersma | | 2017 |
| Biochemical and biomechanical regulation of the myofibroblast phenotype B Piersma | | 2017 |
| Lysyl hydroxylase 2 splice variants are chromatin-associated proteins that regulate transcription of target genes RAF Gjaltema, B Piersma, M Smit, M van der Stoel, S de Rond, MG Rots, ... Modifications of collagen and chromatin in ECM-related disease, 95, 2016 | | 2016 |
| YAP SYNERGIZES WITH THE TGFΒ/SMAD AXIS TO REGULATE PRO-FIBROTIC SIGNALING B Piersma, RAF Gjaltema, S de Rond, T Borghuis, NP Cavanzo, ... | | |
M. BoersemaVerified email at rug.nl